Loopbaan van Sung-Hoon Kim
Eerdere bekende functies van Sung-Hoon Kim
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CUBIST PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 01-01-1993 | 01-01-1994 |
| Oprichter | 01-01-1993 | 01-01-1994 | |
| Seoul National University | Corporate Officer/Principal | - | - |
IMAGENE Co., Ltd.
 IMAGENE Co., Ltd. BiotechnologyHealth Technology IMAGENE Co., Ltd. researches and develops treatment for cancer and infectious diseases. Its products include antibody43, chiral building blocks, and aminoacyl-tRNA synthetase inhibitors. The company was founded on December 1, 1997 and is headquartered in Yongin, South Korea. | Corporate Officer/Principal | 16-06-2011 | - |
Opleiding van Sung-Hoon Kim
| Brown University | Doctorate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| Seoul National University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Zuid-Korea | 3 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
IMAGENE Co., Ltd.
IMAGENE Co., Ltd. BiotechnologyHealth Technology IMAGENE Co., Ltd. researches and develops treatment for cancer and infectious diseases. Its products include antibody43, chiral building blocks, and aminoacyl-tRNA synthetase inhibitors. The company was founded on December 1, 1997 and is headquartered in Yongin, South Korea. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
- Beurs
- Insiders
- Sung-Hoon Kim
- Ervaring
